BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32381600)

  • 1. ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.
    Widmeier E; Yu S; Nag A; Chung YW; Nakayama M; Fernández-Del-Río L; Hugo H; Schapiro D; Buerger F; Choi WI; Helmstädter M; Kim JW; Ryu JH; Lee MG; Clarke CF; Hildebrandt F; Gee HY
    J Am Soc Nephrol; 2020 Jun; 31(6):1191-1211. PubMed ID: 32381600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
    Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
    J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.
    Park E; Kang HG; Choi YH; Lee KB; Moon KC; Jeong HJ; Nagata M; Cheong HI
    Pediatr Nephrol; 2017 Sep; 32(9):1547-1554. PubMed ID: 28405841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific
    Widmeier E; Airik M; Hugo H; Schapiro D; Wedel J; Ghosh CC; Nakayama M; Schneider R; Awad AM; Nag A; Cho J; Schueler M; Clarke CF; Airik R; Hildebrandt F
    J Am Soc Nephrol; 2019 Mar; 30(3):393-405. PubMed ID: 30737270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.
    Yen HC; Liu YC; Kan CC; Wei HJ; Lee SH; Wei YH; Feng YH; Chen CW; Huang CC
    Biochim Biophys Acta; 2016 Sep; 1860(9):1864-76. PubMed ID: 27155576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency.
    Doimo M; Trevisson E; Airik R; Bergdoll M; Santos-Ocaña C; Hildebrandt F; Navas P; Pierrel F; Salviati L
    Biochim Biophys Acta; 2014 Jan; 1842(1):1-6. PubMed ID: 24140869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADCK4 "reenergizes" nephrotic syndrome.
    Malaga-Dieguez L; Susztak K
    J Clin Invest; 2013 Dec; 123(12):4996-9. PubMed ID: 24270414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria Matter: A Critical Role of
    Daehn IS
    J Am Soc Nephrol; 2020 Jun; 31(6):1167-1169. PubMed ID: 32381602
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy.
    Yang J; Yang Y; Hu Z
    Biochem Biophys Res Commun; 2018 Nov; 506(3):444-449. PubMed ID: 30352687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of 6-demethoxyubiquinone in CoQ
    Herebian D; Seibt A; Smits SHJ; Bünning G; Freyer C; Prokisch H; Karall D; Wredenberg A; Wedell A; López LC; Mayatepek E; Distelmaier F
    Mol Genet Metab; 2017 Jul; 121(3):216-223. PubMed ID: 28552678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset of ADCK4 glomerulopathy with renal failure: a case report.
    Lolin K; Chiodini BD; Hennaut E; Adams B; Dahan K; Ismaili K
    BMC Med Genet; 2017 Mar; 18(1):28. PubMed ID: 28298181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.
    Atmaca M; Gulhan B; Korkmaz E; Inozu M; Soylemezoglu O; Candan C; Bayazıt AK; Elmacı AM; Parmaksiz G; Duzova A; Besbas N; Topaloglu R; Ozaltin F
    Pediatr Nephrol; 2017 Aug; 32(8):1369-1375. PubMed ID: 28337616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human mitochondrial PDSS and COQ proteins and their roles in maintaining coenzyme Q
    Yen HC; Yeh WY; Lee SH; Feng YH; Yang SL
    Biochim Biophys Acta Bioenerg; 2020 Jul; 1861(7):148192. PubMed ID: 32194061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
    Korkmaz E; Lipska-Ziętkiewicz BS; Boyer O; Gribouval O; Fourrage C; Tabatabaei M; Schnaidt S; Gucer S; Kaymaz F; Arici M; Dinckan A; Mir S; Bayazit AK; Emre S; Balat A; Rees L; Shroff R; Bergmann C; Mourani C; Antignac C; Ozaltin F; Schaefer F;
    J Am Soc Nephrol; 2016 Jan; 27(1):63-8. PubMed ID: 25967120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in COQ8B (ADCK4) found in patients with steroid-resistant nephrotic syndrome alter COQ8B function.
    Vazquez Fonseca L; Doimo M; Calderan C; Desbats MA; Acosta MJ; Cerqua C; Cassina M; Ashraf S; Hildebrandt F; Sartori G; Navas P; Trevisson E; Salviati L
    Hum Mutat; 2018 Mar; 39(3):406-414. PubMed ID: 29194833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor Kruppel-like factor 5 positively regulates the expression of AarF domain containing kinase 4.
    Chen X; Liu S; Chen J; Wang X; Zhou G
    Mol Biol Rep; 2020 Nov; 47(11):8419-8427. PubMed ID: 33033902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary coenzyme Q10 nephropathy, a potentially treatable form of steroid-resistant nephrotic syndrome.
    Tan W; Airik R
    Pediatr Nephrol; 2021 Nov; 36(11):3515-3527. PubMed ID: 33479824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Long Noncoding RNA H19 Promotes Childhood Nephrotic Syndrome through Inhibiting ADCK4 Signal.
    Xu J; Ge T; Zhou H; Zhang L; Zhao L
    Med Sci Monit; 2020 Jun; 26():e922090. PubMed ID: 32489187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q biosynthesis in health and disease.
    Acosta MJ; Vazquez Fonseca L; Desbats MA; Cerqua C; Zordan R; Trevisson E; Salviati L
    Biochim Biophys Acta; 2016 Aug; 1857(8):1079-1085. PubMed ID: 27060254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.
    Zhang Y; Liao X; Jiang Y; Lv X; Yu Y; Dai Q; Ao L; Tao L; Peng Z
    BMC Nephrol; 2021 Jan; 22(1):11. PubMed ID: 33413146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.